Exercise effects on metabolism and blood-cell networks in people with prediabetes
Official title: Profile and Regulatory Network of Exercise in Improving Metabolic Phenotypes of Patients With Prediabetes
Run by Shanghai Zhongshan Hospital · NCT06633575 · Data updated 2026-11-12
This 8-week exercise program will try to improve weight, lab measures, and blood-cell and metabolic biomarkers in overweight or obese adults with prediabetes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 55 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Shanghai Zhongshan Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | October 12, 2024 |
| Main results expected | October 9, 2027 |
| Study ends | October 9, 2027 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT06633575 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are Han Chinese adults who are overweight or obese with prediabetes-range fasting glucose, 2-hour glucose, or HbA1c, are not on anti-hyperglycemic or weight-loss medications, and can consent to and complete an 8-week exercise program.
✕Probably not a fit
People with uncontrolled hypertension, serious heart/liver/kidney disease, endocrine disorders that affect glucose, recent major weight change, recent use of medications like metformin or GLP-1 agonists, or musculoskeletal problems preventing exercise are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, single-arm self-controlled study will enroll 40 overweight or obese Han Chinese adults with prediabetes for an 8-week supervised exercise program. Clinical measures including body weight, body fat, laboratory blood tests, and resting energy expenditure will be recorded before and after the intervention. Peripheral blood mononuclear cells will be profiled by single-cell sequencing and integrated with metabolomics and phenomic data to identify regulatory networks and potential biomarkers of exercise response. Participants with recent weight-loss interventions, medications affecting metabolism, major organ disease, uncontrolled hypertension, endocrine disorders, or musculoskeletal limitations will be excluded.
Why it matters
Potential benefit: If successful, this work could identify biomarkers and mechanisms that explain how exercise improves metabolism and help tailor lifestyle recommendations for people with prediabetes.
How similar studies have gone: Regular exercise is well-known to improve weight and glycemic measures in prediabetes, but using single-cell and multi-omics profiling to find specific exercise-response biomarkers is relatively novel and not yet proven at scale.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Han Chinese 2. 5.6 mmol/L≤fasting blood glucose\<7 mmol/L, and/or 7.8 mmol/L≤2h-postload glucose\<11.1mmol/L, and/or 5.7% ≤HbA1c\<6.5% without anti-hyperglycemic medicine treatment 3. Voluntary participation and provide informed consent Exclusion Criteria: 1. Participated in any clinical study in relation to weight-loss in the past 1 year 2. Had a weight change of more than 10% present weight in the past 1 year 3. Had a drug usage not suitable for this study in the past 3 months, such as hormone drug, orlistat, metformin, GLP-1 receptor agonists, lipid-lowering agents, liver protection drug, etc 4. Presence of diseases influencing glucose and lipid metabolism ,such as hyperthyroidism, hypothyroidism, Cushing syndrome, etc 5. Poorly controlled blood pressure: systolic blood pressure≥180mmHg, and/or diastolic blood pressure≥100mmHg 6. Presence of serious heart, liver, kidney or systemic diseases 7. Presence of skeletal and muscular diseases which make it difficult to exercise 8. Received any kind of surgery in the past 1 year 9. COVID-19 positive or recovery from COVID-19 within 4 weeks 10. Presence of eating disorders or have a history of eating disorders 11. Presence of sleep disorders 12. Work in disrupted circadian rhythms 13. Pregnancy and breastfeeding women
Where it's running
-
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Ying Chen
- Email: chen.ying4@zs-hospital.sh.cn
- Phone: 86+19542806360
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Hourly stair-climbing snacks to improve blood sugar and heart health in adults with prediabetes
This study tests whether short stair-climbing bursts every hour can improve blood sugar and vascular health in adults with prediabetes.
-
Smart probiotic and nutraceutical approach for cardiometabolic health in older adults
This trial tests whether a probiotic-containing nutraceutical strategy can improve metabolic health and blood pressure in adults over 65 with prediabetes or cardiovascular disease.
-
Family-based diabetes prevention for parents and kids
A family-focused program tests whether a 12-week lifestyle plan can help parents at risk for diabetes lose weight and improve healthy habits for themselves and their children aged 12–17.
-
Cardiorespiratory and muscular fitness in children with obesity and autism
This study tests whether cardiorespiratory fitness and handgrip strength differ between children with obesity who have autism and those who do not, and how these fitness measures relate to body size, composition, and cardiometabolic health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.